-
1
-
-
33644523410
-
Clostridium difficile infection in patients discharged from US short-stay hospital, 1996-2003
-
McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospital, 1996-2003. Emerg Infect Dis 2006, 12:409-415.
-
(2006)
Emerg Infect Dis
, vol.12
, pp. 409-415
-
-
McDonald, L.C.1
Owings, M.2
Jernigan, D.B.3
-
2
-
-
4444382260
-
Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity
-
Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
-
(2004)
CMAJ
, vol.171
, pp. 466-472
-
-
Pepin, J.1
Valiquette, L.2
Alary, M.E.3
Villemure, P.4
Pelletier, A.5
Forget, K.6
-
3
-
-
35148855103
-
Characteristics and incidence Clostridium difficile-associated disease in The Netherlands, 2005
-
Paltansing S., van den Berg R.J., Guseinova R.A., Visser C.E., van der Vorm E.R., Kuijper E.J. Characteristics and incidence Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 2007, 13:1058-1064.
-
(2007)
Clin Microbiol Infect
, vol.13
, pp. 1058-1064
-
-
Paltansing, S.1
van den Berg, R.J.2
Guseinova, R.A.3
Visser, C.E.4
van der Vorm, E.R.5
Kuijper, E.J.6
-
4
-
-
0024545882
-
Nosocomial acquisition of Clostridium difficile infection
-
McFarland L.V., Mulligan M.E., Kwok R.Y., Stann W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
-
(1989)
N Engl J Med
, vol.320
, pp. 204-210
-
-
McFarland, L.V.1
Mulligan, M.E.2
Kwok, R.Y.3
Stann, W.E.4
-
5
-
-
33947105999
-
Incidence of Clostridium difficile infection in inflammatory bowel disease
-
Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339-344.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 339-344
-
-
Rodemann, J.F.1
Dubberke, E.R.2
Reske, K.A.3
Seo da, H.4
Stone, C.D.5
-
6
-
-
0027535757
-
Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile
-
Kochhar R., Ayyagari A., Goenka M.K., Dhali G.K., Aggarwal R., Mehta S.K. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol 1993, 16:26-30.
-
(1993)
J Clin Gastroenterol
, vol.16
, pp. 26-30
-
-
Kochhar, R.1
Ayyagari, A.2
Goenka, M.K.3
Dhali, G.K.4
Aggarwal, R.5
Mehta, S.K.6
-
7
-
-
4644299551
-
The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease
-
Meyer A.M., Ramzan N.N., Loftus E.V., Heigh R.I., Leighton J.A. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004, 38:772-775.
-
(2004)
J Clin Gastroenterol
, vol.38
, pp. 772-775
-
-
Meyer, A.M.1
Ramzan, N.N.2
Loftus, E.V.3
Heigh, R.I.4
Leighton, J.A.5
-
8
-
-
4043089351
-
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool
-
Mylonaki M., Langmead L., Pantes A., Johnson F., Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004, 16:775-778.
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 775-778
-
-
Mylonaki, M.1
Langmead, L.2
Pantes, A.3
Johnson, F.4
Rampton, D.S.5
-
9
-
-
33947111354
-
Impact of Clostridium difficile on inflammatory bowel disease
-
Issa M., Vijayapal A., Graham M.B., Beaulieu D.B., Otterson M.F., Lundeen S., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345-351.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 345-351
-
-
Issa, M.1
Vijayapal, A.2
Graham, M.B.3
Beaulieu, D.B.4
Otterson, M.F.5
Lundeen, S.6
-
10
-
-
44949261865
-
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
-
Nguyen G.C., Kaplan G.G., Harris M.L., Brant S.R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:1443-1450.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1443-1450
-
-
Nguyen, G.C.1
Kaplan, G.G.2
Harris, M.L.3
Brant, S.R.4
-
11
-
-
64049106774
-
Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel disease
-
Ricciardi R., Ogilvie J.W., Roberts P.L., Marcello P.W., Concannon T.W., Baxter N.N. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel disease. Dis Colon Rectum 2009, 52:40-45.
-
(2009)
Dis Colon Rectum
, vol.52
, pp. 40-45
-
-
Ricciardi, R.1
Ogilvie, J.W.2
Roberts, P.L.3
Marcello, P.W.4
Concannon, T.W.5
Baxter, N.N.6
-
13
-
-
38549093523
-
Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease
-
Ananthakrishnan A.N., McGinley E.L., Binion D.G. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205-210.
-
(2008)
Gut
, vol.57
, pp. 205-210
-
-
Ananthakrishnan, A.N.1
McGinley, E.L.2
Binion, D.G.3
-
14
-
-
70350777681
-
Long-term impact of Clostridium difficile on inflammatory bowel disease
-
Chiplunker A., Ananthakrishnan A.N., Beaulieu D.B., Naik A.S., Zadvormova Y., Skaros S., et al. Long-term impact of Clostridium difficile on inflammatory bowel disease. Gastroenterology. 2009, 136(Suppl. 1):A-199.
-
(2009)
Gastroenterology.
, vol.136
, Issue.SUPPL. 1
-
-
Chiplunker, A.1
Ananthakrishnan, A.N.2
Beaulieu, D.B.3
Naik, A.S.4
Zadvormova, Y.5
Skaros, S.6
-
15
-
-
43049129555
-
Risk factors for the development of fulminant Clostridium difficile colitis
-
Greenstein A.J., Byrn J.C., Zhang L.P., Swedish K.A., Jahn A.E., Divino C.M. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery 2008, 143:623-629.
-
(2008)
Surgery
, vol.143
, pp. 623-629
-
-
Greenstein, A.J.1
Byrn, J.C.2
Zhang, L.P.3
Swedish, K.A.4
Jahn, A.E.5
Divino, C.M.6
-
16
-
-
58149193446
-
Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study
-
Matsumoto T., Andoh A., Okawa K., Ito H., Torii A., Yoshikawa S., et al. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Ther Apher Dial 2008, 12:484-490.
-
(2008)
Ther Apher Dial
, vol.12
, pp. 484-490
-
-
Matsumoto, T.1
Andoh, A.2
Okawa, K.3
Ito, H.4
Torii, A.5
Yoshikawa, S.6
-
17
-
-
0008690916
-
Cortisone in ulcerative colitis; final report on a therapeutic trial
-
Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955, 2:1041-1048.
-
(1955)
Br Med J.
, vol.2
, pp. 1041-1048
-
-
Truelove, S.C.1
Witts, L.J.2
-
19
-
-
0036111857
-
Role of infections in the manifestation or reactivation of inflammatory bowel disease
-
Stallmach A., Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel disease. Inflamm Bowel Dis 2002, 8:213-218.
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 213-218
-
-
Stallmach, A.1
Carstens, O.2
-
20
-
-
38549098176
-
Prognosis in Clostridium difficile infection complicating inflammatory bowel disease
-
Stone C.D. Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Gut 2008, 57:150-152.
-
(2008)
Gut
, vol.57
, pp. 150-152
-
-
Stone, C.D.1
-
21
-
-
0025880322
-
Clostridium difficile in inflammatory bowel disease relapse
-
Gryboski J.D. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr 1991, 13:39-41.
-
(1991)
J Pediatr Gastroenterol Nutr
, vol.13
, pp. 39-41
-
-
Gryboski, J.D.1
-
22
-
-
41149119335
-
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
-
Viget N., Vernier-Massouille G., Salmon-Ceron D., Yazdanpanah Y., Colombel J.F. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008, 57:549-558.
-
(2008)
Gut
, vol.57
, pp. 549-558
-
-
Viget, N.1
Vernier-Massouille, G.2
Salmon-Ceron, D.3
Yazdanpanah, Y.4
Colombel, J.F.5
-
23
-
-
67349197840
-
Impact of Clostridium difficile infection on pediatric inflammatory bowel disease
-
Pascarella F., Martinelli M., Miele E., Del Pezzo M., Roscetto E., Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009, 154:854-858.
-
(2009)
J Pediatr
, vol.154
, pp. 854-858
-
-
Pascarella, F.1
Martinelli, M.2
Miele, E.3
Del Pezzo, M.4
Roscetto, E.5
Staiano, A.6
-
24
-
-
77149140102
-
Clostridium difficile infection and inflammatory bowel disease
-
Musa S., Thomson S., Cowan M., Rahman T. Clostridium difficile infection and inflammatory bowel disease. Scand J Gastroenterol 2010, 45:261-272.
-
(2010)
Scand J Gastroenterol
, vol.45
, pp. 261-272
-
-
Musa, S.1
Thomson, S.2
Cowan, M.3
Rahman, T.4
-
25
-
-
48249135038
-
Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent?
-
Powell N., Jung S.E., Krishnan B. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent?. Gut 2008, 57:1183-1184.
-
(2008)
Gut
, vol.57
, pp. 1183-1184
-
-
Powell, N.1
Jung, S.E.2
Krishnan, B.3
-
26
-
-
69249181666
-
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection
-
Ben-Horin S., Margalit M., Bossuyt P., Maul J., Shapira Y., Bojic D., et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol 2009, 7:981-987.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 981-987
-
-
Ben-Horin, S.1
Margalit, M.2
Bossuyt, P.3
Maul, J.4
Shapira, Y.5
Bojic, D.6
-
27
-
-
67650430007
-
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
-
Schneeweiss S., Korzenik J., Solomon D.H., Canning C., Lee J., Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009, 30:253-264.
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 253-264
-
-
Schneeweiss, S.1
Korzenik, J.2
Solomon, D.H.3
Canning, C.4
Lee, J.5
Bressler, B.6
-
28
-
-
0037204196
-
Antibiotic-associated diarrhea
-
Bartlett J.G., Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
-
(2002)
N Engl J Med
, vol.346
, pp. 334-339
-
-
Bartlett, J.G.1
Clinical, P.2
-
29
-
-
0035436311
-
Epidemiology of Clostridium difficile-associated infection
-
Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infection. Clin Microbiol Infect 2001, 7:405-410.
-
(2001)
Clin Microbiol Infect
, vol.7
, pp. 405-410
-
-
Barbut, F.1
Petit, J.C.2
-
30
-
-
34848836638
-
Increase in Clostridium difficile-related mortality rates, United States, 1999-2004
-
Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
-
(2007)
Emerg Infect Dis
, vol.13
, pp. 1417-1419
-
-
Redelings, M.D.1
Sorvillo, F.2
Mascola, L.3
-
31
-
-
0031752883
-
Risk factors for Clostridium difficile infection
-
Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 1998, 40:1-15.
-
(1998)
J Hosp Infect
, vol.40
, pp. 1-15
-
-
Bignardi, G.E.1
-
32
-
-
58849083648
-
Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease
-
Bossuyt P., Verhaegen J., Van Assche G., Rutgeerts P., Vermeire S. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohn's Colitis 2009, 3:4-7.
-
(2009)
J Crohn's Colitis
, vol.3
, pp. 4-7
-
-
Bossuyt, P.1
Verhaegen, J.2
Van Assche, G.3
Rutgeerts, P.4
Vermeire, S.5
-
33
-
-
3142705643
-
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies
-
Dial S., Alrasadi K., Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004, 171:33-38.
-
(2004)
CMAJ
, vol.171
, pp. 33-38
-
-
Dial, S.1
Alrasadi, K.2
Manoukian, C.3
Huang, A.4
Menzies, D.5
-
34
-
-
29144473282
-
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
-
Dial S., Delaney J.A., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294:2989-2995.
-
(2005)
JAMA
, vol.294
, pp. 2989-2995
-
-
Dial, S.1
Delaney, J.A.2
Barkun, A.N.3
Suissa, S.4
-
35
-
-
34547814762
-
Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools
-
Hauben M., Horn S., Reich L., Younus M. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. Int J Infect Dis 2007, 11:417-422.
-
(2007)
Int J Infect Dis
, vol.11
, pp. 417-422
-
-
Hauben, M.1
Horn, S.2
Reich, L.3
Younus, M.4
-
36
-
-
50649112615
-
Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients
-
Aseeri M., Schroeder T., Kramer J., Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008, 103:2308-2313.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2308-2313
-
-
Aseeri, M.1
Schroeder, T.2
Kramer, J.3
Zackula, R.4
-
37
-
-
76849114352
-
Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection
-
Jodorkovsky D., Young Y., Abreu M.T. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010, 55:415-420.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 415-420
-
-
Jodorkovsky, D.1
Young, Y.2
Abreu, M.T.3
-
38
-
-
38749106156
-
European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis
-
Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008, 2:1-23.
-
(2008)
J Crohn's Colitis
, vol.2
, pp. 1-23
-
-
Stange, E.F.1
Travis, S.P.2
Vermeire, S.3
Reinisch, W.4
Geboes, K.5
Barakauskiene, A.6
-
39
-
-
66949151443
-
The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission
-
Clayton E.M., Rea M.C., Shanahan F., Quigley E.M., Kiely B., Hill C., et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009, 104:1162-1169.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1162-1169
-
-
Clayton, E.M.1
Rea, M.C.2
Shanahan, F.3
Quigley, E.M.4
Kiely, B.5
Hill, C.6
-
40
-
-
0020069201
-
Isolation of Clostridium difficile from patients with inactive Crohn's disease
-
Dorman S.A., Liggoria E., Winn W.C., Beeken W.L. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology 1982, 82:1348-1351.
-
(1982)
Gastroenterology
, vol.82
, pp. 1348-1351
-
-
Dorman, S.A.1
Liggoria, E.2
Winn, W.C.3
Beeken, W.L.4
|